OTC Drug And Dietary Supplement Global Market Report 2026
상품코드:1957558
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
일반의약품 및 식이보충제 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 3,524억 달러에서 2026년에는 3,763억 2,000만 달러에 이르고, CAGR 6.8%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 셀프메디케이션의 확산, 헬스케어에 대한 인식 개선, 소매 약국 네트워크의 확대, 고령화 인구 증가, 시판약의 접근성에 대한 규제적 지원 등을 꼽을 수 있습니다.
일반용 의약품 및 식이보충제 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 4,978억 4,000만 달러에 이르고, CAGR은 7.2%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 전자상거래 헬스케어 플랫폼의 확대, 면역 및 건강 증진 제품에 대한 수요 증가, 영양 보충제 연구의 발전, 도시형 라이프 스타일과 관련된 건강 문제, 신흥 경제국의 가처분 소득 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 트렌드에는 AI를 활용한 제품 개인화, 정밀 영양학 및 질환별 보충제, 디지털 우선 및 옴니채널 소매 확대, 지속 가능한 클린 라벨 처방, 스마트 패키징, 커넥티드 건강 모니터링 등이 포함됩니다.
의약품 R&D 비용 증가는 향후 몇 년 동안 시판약 및 건강기능식품 시장의 성장을 가속할 것으로 예측됩니다. R&D 투자는 기업이 제품 개발, 설계 및 개선에 소요되는 비용을 의미하며, 시판약 및 건강기능식품의 처방 설계에 있어 혁신성과 생산성을 뒷받침하는 요소입니다. 연구개발비 증가는 주로 제품 효과 향상, 안전성 확보, 치열한 경쟁 시장에서 차별화를 꾀하는 기업들에 의해 주도되고 있습니다. 예를 들어, 미국 정부 통계 기관인 국립과학기술통계센터(NCSES)에 따르면, 2025년 2월 기준 미국의 R&D 지출은 2022년 8,920억 달러에서 2023년 9,400억 달러로 4,800억 달러 증가하였습니다. 따라서 의약품 연구개발에 대한 투자 확대는 시판약 및 건강기능식품 시장의 성장에 기여하고 있습니다.
시판약 및 건강기능식품 시장에서 사업을 영위하는 주요 기업들은 시장 지위를 유지하기 위해 경구용 피임약과 같은 혁신적인 제품을 도입하는 데 주력하고 있습니다. 경구 피임약은 임신을 예방하기 위해 1일 1회 경구 복용하는 의약품으로, 에스트로겐과 프로게스틴의 조합 또는 프로게스틴 단독으로 복용하는 약품입니다. 예를 들어, 2023년 7월 아일랜드에 본사를 둔 셀프케어 기업 페리고 컴퍼니(Perigo Company PLC, 다양한 시판용 소비자 건강 제품 및 의약품을 제조)는 중요한 이정표를 세웠습니다. 미국 식품의약국(FDA)이 프로게스틴 단일 성분의 매일 복용하는 경구 피임약 '오필'을 전 연령층에 대한 시판 허가를 내준 것입니다. 이 획기적인 승인으로 오필은 미국에서 처방전 없이 구입할 수 있는 최초의 피임약이 되었습니다. 패트릭 록우드-테일러(Patrick Lockwood-Taylor) 페리고 사장 겸 최고경영자(CEO)는 이번 결정이 여성 건강에 역사적으로 중요한 결정이며, 피임에 대한 접근성을 변화시킬 수 있는 잠재력을 가지고 있다고 강조했습니다. 이러한 발전은 전국적으로 건강 결과를 개선하는 의미 있는 솔루션을 지속적으로 제공하려는 페리고의 지속적인 노력을 반영합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
OTC drugs are pharmaceutical products that can be purchased without a prescription and are commonly used to manage minor medical conditions, while dietary supplements are designed to increase the intake of specific nutrients or bioactive compounds in the diet and are not intended to treat, prevent, or cure diseases. OTC drugs provide fast symptom relief and address specific health concerns, whereas dietary supplements offer additional nutritional support to promote overall wellness and support the body's natural health maintenance. Together, they contribute to a broad approach to self-care and preventive health.
The main categories of OTC drugs and dietary supplements include vitamins and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others. Vitamins and dietary supplements are chemical substances required by the body in small quantities for various metabolic processes that support general health and help manage different medical conditions. These products are available in dosage forms such as tablets, hard capsules, powders, ointments, soft capsules, liquids, and others, and are sold through pharmacies, grocery stores, vitamin and health food stores, and online pharmacies.
Tariffs have influenced the otc drug and dietary supplement market by increasing the cost of imported active ingredients, excipients, and packaging materials, leading to pricing pressure across vitamins, analgesics, and gastrointestinal products. Regions heavily dependent on cross-border supply chains, particularly asia-pacific and north america, are most affected, while online pharmacy and private-label segments face margin constraints. However, tariffs have also encouraged local manufacturing, supply chain diversification, and regional sourcing, supporting domestic production capabilities and long-term market resilience.
The otc drug and dietary supplement market research report is one of a series of new reports from The Business Research Company that provides otc drug and dietary supplement market statistics, including otc drug and dietary supplement industry global market size, regional shares, competitors with a otc drug and dietary supplement market share, detailed otc drug and dietary supplement market segments, market trends and opportunities, and any further data you may need to thrive in the otc drug and dietary supplement industry. This otc drug and dietary supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The otc drug and dietary supplement market size has grown strongly in recent years. It will grow from $352.4 billion in 2025 to $376.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising prevalence of self-medication, increasing awareness of preventive healthcare, expansion of retail pharmacy networks, growing aging population, regulatory support for otc drug availability.
The otc drug and dietary supplement market size is expected to see strong growth in the next few years. It will grow to $497.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growth of e-commerce healthcare platforms, increasing demand for immunity and wellness products, advancements in nutraceutical research, urban lifestyle-related health issues, rising disposable income in emerging economies. Major trends in the forecast period include ai-driven product personalization, precision nutrition and condition-specific supplements, digital-first and omnichannel retail expansion, sustainable and clean-label formulations, smart packaging and connected health monitoring.
The increasing expenditure on pharmaceutical research and development is expected to drive the growth of the OTC drug and dietary supplement market in the coming years. Research and development investment refers to the costs incurred by companies to develop, design, and improve their products, which supports innovation and productivity in the formulation and design of OTC drugs and dietary supplements. The rise in research and development spending is largely driven by companies seeking to enhance product effectiveness, ensure safety, and achieve differentiation in a highly competitive market. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, research and development expenditures in the United States increased from $892 billion in 2022 to $940 billion in 2023, representing a rise of $48 billion. Therefore, the growing investment in pharmaceutical R&D is contributing to the expansion of the OTC drug and dietary supplement market.
Major companies operating in the OTC drug and dietary supplement market are emphasizing the introduction of innovative products, such as oral contraceptives, to maintain their market position. Oral contraceptive pills are medications taken orally once a day to prevent pregnancy and contain either a combination of estrogen and progestin or progestin alone. For example, in July 2023, Perrigo Company PLC, an Ireland-based self-care company that manufactures a wide range of over-the-counter consumer health and pharmaceutical products, reached a significant milestone when the U.S. Food and Drug Administration approved Opill, a progestin-only daily oral contraceptive, for over-the-counter availability for all age groups. This landmark approval made Opill the first birth control pill available without a prescription in the United States. Perrigo's President and Chief Executive Officer, Patrick Lockwood-Taylor, highlighted the historic importance of this decision for women's health, noting its potential to transform access to contraception. This development reflects Perrigo's continued commitment to delivering meaningful solutions that enhance health outcomes nationwide.
In January 2025, Wellful, a US-based provider of omnichannel health and wellness solutions, acquired Ancient Nutrition for an undisclosed amount. Through this acquisition, Wellful seeks to strengthen its presence in the vitamin, mineral, and dietary supplement segments while expanding its reach within the natural retail channel. Ancient Nutrition is a US-based company known for offering high-quality dietary supplements.
Major companies operating in the otc drug and dietary supplement market are Pfizer Inc., Johnson & Johnson Ltd., Bayer AG, Sanofi S.A, Abbott Laboratories Inc, GSK plc, Reckitt Benckiser Plc., Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Church & Dwight Co Inc, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Cipla Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd, Nutraceutical International Corporation, Procter & Gamble Health Limited, UPM Pharmaceuticals Inc, Pharmavite LLC, Now Health Group Inc., Alfresa Pharma Corporation
North America was the largest region in the OTC drug and dietary supplement market in 2025. The regions covered in the otc drug and dietary supplement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the otc drug and dietary supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The OTC drug and dietary supplement market consist of sales of pain relievers, omega-3 fatty acids, probiotics, and herbal supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
OTC Drug And Dietary Supplement Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses otc drug and dietary supplement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for otc drug and dietary supplement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The otc drug and dietary supplement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Category: Vitamin And Dietary Supplements; Cough And Cold Products; Analgesics; Gastrointestinal Products; Sleep Aids; Otic Products; Wart Removers; Mouth Care Products; Ophthalmic Products; Other Categories
2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
3) By Application: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
Subsegments:
1) By Vitamin And Dietary Supplements: Multivitamins; Mineral Supplements; Herbal Supplements; Omega-3 Fatty Acids; Probiotics; Specialty Supplements
2) By Cough And Cold Products: Cough Suppressants; Expectorants; Decongestants; Combination Products
3) By Analgesics: Acetaminophen; NSAIDs; Topical Analgesics
4) By Gastrointestinal Products: Antacids; Laxatives; Antidiarrheals; Proton Pump Inhibitors
5) By Sleep Aids: Melatonin; Antihistamines; Herbal Sleep Aids
6) By Otic Products: Ear Wax Removal Aids; Ear Drops For Infections; Anti-itch Ear Products
7) By Wart Removers: Salicylic Acid Products; Cryotherapy Kits
8) By Mouth Care Products: Mouthwashes; Toothpastes; Oral Rinses For Freshness
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Ai-Driven Product Personalization
4.2.2 Precision Nutrition And Condition-Specific Supplements
4.2.3 Digital-First And Omnichannel Retail Expansion
4.2.4 Sustainable And Clean-Label Formulations
4.2.5 Smart Packaging And Connected Health Monitoring
5. OTC Drug And Dietary Supplement Market Analysis Of End Use Industries
5.1 Pharmacies
5.2 Grocery Stores
5.3 Vitamin And Health Food Stores
5.4 Online Pharmacies
5.5 Drug Manufacturers
6. OTC Drug And Dietary Supplement Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global OTC Drug And Dietary Supplement Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global OTC Drug And Dietary Supplement PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global OTC Drug And Dietary Supplement Market Size, Comparisons And Growth Rate Analysis
7.3. Global OTC Drug And Dietary Supplement Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global OTC Drug And Dietary Supplement Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global OTC Drug And Dietary Supplement Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. OTC Drug And Dietary Supplement Market Segmentation
9.1. Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other Categories
9.2. Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms
9.3. Global OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmacies, Grocery Stores, Vitamin And Health Food Stores, Online Pharmacies
9.4. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Vitamin And Dietary Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Cough And Cold Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Acetaminophen, NSAIDs, Topical Analgesics
9.7. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Gastrointestinal Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Sleep Aids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Melatonin, Antihistamines, Herbal Sleep Aids
9.9. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Otic Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Wart Removers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Salicylic Acid Products, Cryotherapy Kits
9.11. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Mouth Care Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Mouthwashes, Toothpastes, Oral Rinses For Freshness
9.12. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Ophthalmic Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.13. Global OTC Drug And Dietary Supplement Market, Sub-Segmentation Of Other Categories, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Nutraceuticals, Topical Treatments For Skin Conditions, First Aid Products
10. OTC Drug And Dietary Supplement Market Regional And Country Analysis
10.1. Global OTC Drug And Dietary Supplement Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global OTC Drug And Dietary Supplement Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific OTC Drug And Dietary Supplement Market
11.1. Asia-Pacific OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China OTC Drug And Dietary Supplement Market
12.1. China OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India OTC Drug And Dietary Supplement Market
13.1. India OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan OTC Drug And Dietary Supplement Market
14.1. Japan OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia OTC Drug And Dietary Supplement Market
15.1. Australia OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia OTC Drug And Dietary Supplement Market
16.1. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea OTC Drug And Dietary Supplement Market
17.1. South Korea OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan OTC Drug And Dietary Supplement Market
18.1. Taiwan OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia OTC Drug And Dietary Supplement Market
19.1. South East Asia OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe OTC Drug And Dietary Supplement Market
20.1. Western Europe OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK OTC Drug And Dietary Supplement Market
21.1. UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany OTC Drug And Dietary Supplement Market
22.1. Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France OTC Drug And Dietary Supplement Market
23.1. France OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy OTC Drug And Dietary Supplement Market
24.1. Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain OTC Drug And Dietary Supplement Market
25.1. Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe OTC Drug And Dietary Supplement Market
26.1. Eastern Europe OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia OTC Drug And Dietary Supplement Market
27.1. Russia OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America OTC Drug And Dietary Supplement Market
28.1. North America OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA OTC Drug And Dietary Supplement Market
29.1. USA OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada OTC Drug And Dietary Supplement Market
30.1. Canada OTC Drug And Dietary Supplement Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America OTC Drug And Dietary Supplement Market
31.1. South America OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil OTC Drug And Dietary Supplement Market
32.1. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East OTC Drug And Dietary Supplement Market
33.1. Middle East OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa OTC Drug And Dietary Supplement Market
34.1. Africa OTC Drug And Dietary Supplement Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa OTC Drug And Dietary Supplement Market, Segmentation By Category, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. OTC Drug And Dietary Supplement Market Regulatory and Investment Landscape
36. OTC Drug And Dietary Supplement Market Competitive Landscape And Company Profiles
36.1. OTC Drug And Dietary Supplement Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. OTC Drug And Dietary Supplement Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. OTC Drug And Dietary Supplement Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Johnson & Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Abbott Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
37. OTC Drug And Dietary Supplement Market Other Major And Innovative Companies
GSK plc, Reckitt Benckiser Plc., Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Church & Dwight Co Inc, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Cipla Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd, Nutraceutical International Corporation, Procter & Gamble Health Limited, UPM Pharmaceuticals Inc
38. Global OTC Drug And Dietary Supplement Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The OTC Drug And Dietary Supplement Market
40. OTC Drug And Dietary Supplement Market High Potential Countries, Segments and Strategies
40.1 OTC Drug And Dietary Supplement Market In 2030 - Countries Offering Most New Opportunities
40.2 OTC Drug And Dietary Supplement Market In 2030 - Segments Offering Most New Opportunities
40.3 OTC Drug And Dietary Supplement Market In 2030 - Growth Strategies
